Jinying Chen
P.R. China
Guangzhou, 510630, China
Guangzhou, 510630, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Regulatory mechanisms and therapeutic potential of N6-methyladenosine modification in retinal diseases (Review).
Journal: Molecular medicine reports
Published: January 13, 2026
Cumulative loneliness and social isolation are associated with incident glaucoma in Chinese and US cohorts.
Journal: Scientific reports
Published: December 12, 2025
An Integrative Multi-Omics Analysis Reveals MicroRNA-143 as a Potential Therapeutic to Attenuate Retinal Angiogenesis.
Journal: Nucleic acid therapeutics
Published: April 01, 2022
TAK1 blockade as a therapy for retinal neovascularization.
Journal: Pharmacological research
Published: March 23, 2022
NLRC5 regulates expression of MHC-I and provides a target for anti-tumor immunity in transmissible cancers.
Journal: Journal of cancer research and clinical oncology
Published: January 18, 2021
Targeted delivery of LM22A-4 by cubosomes protects retinal ganglion cells in an experimental glaucoma model.
Journal: Acta biomaterialia
Published: October 16, 2020
Comparison of CRISPR/Cas Endonucleases for in vivo Retinal Gene Editing.
Journal: Frontiers in cellular neuroscience
Published: June 09, 2020
A drug-tunable Flt23k gene therapy for controlled intervention in retinal neovascularization.
Journal: Angiogenesis
Published: February 03, 2020
Methods for Assessing Scaffold Vascularization In Vivo.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: May 31, 2019
Gene therapy for visual loss: Opportunities and concerns.
Journal: Progress in retinal and eye research
Published: February 21, 2018
A novel method of neural differentiation of PC12 cells by using Opti-MEM as a basic induction medium.
Journal: International journal of molecular medicine
Published: April 05, 2017
Last Updated: 09/26/2026